Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
EP1.14 - Targeted Therapy
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
EP1.14-13 - EGFR Mutation in Lung Adenocarcinoma: Real World Study from a Single Institute
08:00 - 08:00 | Presenter: Gebang Wang | Author(s): Chenlei Zhang, Wenyuan Shang, JINGHAN Li, HAICHAO Sun, Zhanwu Yu, Hong-Xu Liu
- Abstract
Loading...
-
+
EP1.18 - Treatment of Locoregional Disease - NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
EP1.18-20 - Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Initial Short-Term Results from a Single Institute in Northeast China
08:00 - 08:00 | Presenter: Hong-Xu Liu | Author(s): Yegang Ma, Zhanwu Yu, Chenlei Zhang, Gebang Wang, Hongxi Liu, Guan Wang
- Abstract
Loading...
-
+
P1.17 - Treatment of Early Stage/Localized Disease
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P1.17-20 - Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Lung Cancer
09:45 - 09:45 | Presenter: Chenlei Zhang | Author(s): Gebang Wang, Zhanwu Yu, Hong-Xu Liu
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-06 - The Study of Rac3 Molecular Mechanism Through ERK Signaling Pathway in Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Hong-Xu Liu | Author(s): JINGHAN Li, HAICHAO Sun, Gebang Wang, Chenlei Zhang, YI Zhang, Guan Wang, PENG Zu
- Abstract
Loading...
-
+
ES23 - Optimal Management of N2 Disease in the Era Of IO
- 11:30 - 13:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Alex Martinez-Marti, Hong-Xu Liu
-
+
Introduction/Poll
11:30 - 11:30
- Abstract
No abstract available for this presentation
-
+
ES23.01 - Mediastinoscopy with Invasive Staging: Are They Still Crucial?
11:30 - 11:45 | Presenter: Akif Turna
- Abstract
Loading... -
+
ES23.02 - Which N2 Patients Are Candidates to Surgery in the Era If I/O?
11:45 - 12:00 | Presenter: Eric Vallieres
- Abstract
Loading... -
+
ES23.03 - Is CT/RT Followed by I/O the Standard of Care for All N2 and Selected N3 Patients?
12:00 - 12:15 | Presenter: Wilfried Ernst Erich Eberhardt
- Abstract
Loading... -
+
ES23.04 - Optimal Supportive Care During and After Concurrent Chemoradiotherapy and I/O
12:15 - 12:30 | Presenter: Dirk De Ruysscher | Author(s): Kristiaan Nakaerts
- Abstract
Loading... -
+
ES23.05 - The Future of Systemic Therapy in Stage III
12:30 - 12:45 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
ES23.06 - Q&A
12:45 - 13:00
- Abstract
No abstract available for this presentation
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.12 - Discussant - MA21.09, MA21.10, MA21.11
15:45 - 16:00 | Presenter: Hong-Xu Liu
- Abstract
No abstract available for this presentation
